Eisai Co., Ltd. is engaged in the research and development, manufacture, sale and import and export of pharmaceuticals. The Company's business segments include pharmaceutical segment and other segment. The pharmaceutical segment is engaged in the research, develop, manufacture and sale of pharmaceuticals for medical use, generic drugs, general medicines, among others. The other segment consists of pharmaceutical raw materials, logistics services and business services businesses.

Shin Kato

VP, General Counsel, Chief Compliance Officer, Intellectual Property Internal Control at Eisai

Org chart

Teams

Legal & Compliance

Offices

Related people

Chad Downie

Spencer Collins

Jonathan Brockmeier

Dan Zmijewski

Linda Lacewell